ProCE Banner Activity


Acknowledging Patient Preferences (Goals) and Promoting Enrollment on Clinical Trials for Patients With Ovarian Cancer

Listen to this interactive virtual presentation by Kimberly J. Halla, MSN, FNP-C, discussing patient preferences influencing treatments and minority women enrollment in clinical trials of ovarian cancer.

Pharmacists: 0.25 contact hour (0.025 CEUs)

Physicians: Maximum of 0.25 AMA PRA Category 1 Credit

Nurses: 0.25 Nursing contact hour

Released: October 15, 2021

Expiration: October 14, 2022

No longer available for credit.



Kimberly J. Halla

Kimberly J. Halla, MSN, FNP-C

Family Nurse Practitioner
Arizona Oncology
Phoenix, Arizona

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner


Supported by educational grants from



Merck Sharp & Dohme Corp.


Smart Patients

ProCE Banner

Target Audience

This educational program is intended for oncologists, oncology nurses, oncology pharmacists, and other healthcare providers who care for patients with gynecologic malignancies.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Describe to patients the risk factors and importance of screening, the benefits of clinical trial enrollment, and how their disease risk and clinical outcomes may differ from other patients


Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Faculty Disclosure

Primary Author

Kimberly J. Halla, MSN, FNP-C

Family Nurse Practitioner
Arizona Oncology
Phoenix, Arizona

Kimberly J. Halla, MSN, FNP-C, has disclosed that she has received consulting fees from GlaxoSmithKline, Merck, and Seattle Genetics.

Staff Disclosure


Eloise Chapman-Davis, MD, FACOG

Gynecologic Oncologist
Associate Professor of OB/GYN
Department of OB/GYN
Division of Gynecologic Oncology
Weill Cornell Medicine-NewYork Presbyterian Hospital
New York, New York

Eloise Chapman-Davis, MD, FACOG, has no relevant conflicts of interest to report.

Jerfiz Constanzo, PhD, MBA

Scientific Director

Jerfiz D. Constanzo, PhD, MBA, has no relevant conflicts of interest to report.

Jason J. Everly, PharmD

Jason Everly, PharmD, BCOP, CHCP, has no relevant conflicts of interest to disclose.

Gordon Kelley,

Clinical Editor
Clinical Care Options, LLC

Gordon Kelley, has no relevant conflicts of interest to report.

Krista Marcello,

Associate Managing Editor

Krista Marcello, has no relevant conflicts of interest to report.

Jim Mortimer,

Product Director, Hematology/Oncology
Clinical Care Options, LLC

Jim Mortimer, has no relevant conflicts of interest to report.

Kara Nyberg, PhD

Editorial Contributor

Kara Nyberg, PhD, has no relevant conflicts of interest to report.

Kevin Obholz, PhD

Editorial Director, Hematology/Oncology

Kevin Obholz, PhD, has no relevant conflicts of interest to report.

Timothy A. Quill, PhD

Senior Managing Editor

Timothy A. Quill, PhD, has no relevant conflicts of interest to report.

June Wasserstrom,

Director, CME Program Development

June Wasserstrom, has no relevant conflicts of interest to report.

Instructions for Credit


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit Designation

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.25 contact hours.

Credit Designation

CCO designates this continuing education activity for 0.25 contact hours (0.025 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-21-221-H01-P.

Type of Activity: Knowledge

Upon successfully completing the post-test with a score of 100% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Additional Information

Participation in this self-study activity should be completed in approximately 0.25 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from October 15, 2021, through October 14, 2022:

1. Register online at
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 100% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.


The goal of this activity is to educate oncologists, oncology nurses, pharmacists, and other healthcare professionals about recent developments in the care of gynecologic malignancies and raise awareness of disparities in care to optimally individualize therapy for this patient population.